뒤로Viruses: Structure, Replication, and Acellular Infectious Agents – Study Notes (Microbiology Chapter 13)
스터디 가이드 - 스마트 노트
자료에 맞춘 맞춤형 노트, 핵심 정의, 예시, 맥락을 확장해 제공합니다.
Viruses: Structure and Host Range
What Defines a Virus
Viruses are unique infectious agents that differ fundamentally from cellular life forms. They are acellular, lack independent metabolism, and require living host cells for replication.
Acellular Organization: Viruses are not cells; they lack ribosomes, cytoplasm, and energy-producing systems.
Obligate Intracellular Parasites: Viruses must infect living cells to reproduce; they do not divide by binary fission but assemble new particles from components.
Virion: The complete, infectious virus particle outside a host cell.
Capsid: Protein shell made of capsomeres, protecting the viral genome and often aiding in attachment.
Nucleocapsid: The viral genome plus its capsid.
Envelope: An optional lipid membrane derived from the host, containing viral proteins (often glycoprotein spikes).
Shapes: Helical, polyhedral/icosahedral, and complex (e.g., tailed bacteriophages).
Feature | Viruses | Cellular Organisms |
|---|---|---|
Organization | Acellular particles | Cells with membranes, cytoplasm, ribosomes |
Genome | DNA or RNA; single- or double-stranded; may be segmented | DNA genome; RNA for gene expression |
Replication | Host-dependent synthesis and assembly | Cell growth and division |
Metabolism | No independent ATP production or protein synthesis | Own metabolic machinery |
Why Not Living? Viruses cannot independently metabolize, maintain homeostasis, or reproduce. However, they possess genomes and can evolve.
Host Range and Tissue Tropism
The host range of a virus is determined by the compatibility between viral attachment proteins and host cell receptors, as well as internal cellular factors.
Host Range: The spectrum of species or cell types a virus can infect.
Tropism: Preference for specific tissues or cell types within a host.
Attachment: Viral proteins must match host receptors (e.g., HIV binds CD4 and a coreceptor).
Example: Bacteriophages infect bacteria; tail fibers recognize specific bacterial molecules.
Discovery and Structure of Viruses
The Tobacco Mosaic Filtration Experiment
Early experiments established viruses as filterable infectious agents distinct from bacteria.
Ivanovsky (1892): Filtered sap from diseased tobacco leaves through bacteria-retaining porcelain; filtrate remained infectious.
Beijerinck (1898): Concluded a distinct, filterable agent multiplied in plants—later identified as tobacco mosaic virus.
Key Point: Filtration showed the agent was smaller than bacteria but did not directly prove acellularity.
Naked Versus Enveloped Virions
Viruses can be classified based on the presence or absence of an envelope, which affects their stability and transmission.
Feature | Naked/Nonenveloped | Enveloped |
|---|---|---|
Outer Surface | Protein capsid | Lipid envelope with viral proteins |
Acquisition | No envelope acquired | Budding through host membranes |
Environmental Survival | More resistant to drying, detergents, acid | More vulnerable to drying, heat, solvents |
Release | Often cell lysis | Often budding or secretion |
Examples | Adenovirus, poliovirus, norovirus | Influenza virus, HIV, herpesviruses |
Envelope Origin: Derived from host membrane, but with inserted viral proteins.
Clinical Note: Enveloped viruses are generally more sensitive to detergents due to their lipid layer.
Bacteriophage Replication
Lytic Versus Lysogenic Cycles
Bacteriophages (phages) can replicate via two main cycles: lytic and lysogenic.
Feature | Lytic | Lysogenic |
|---|---|---|
Immediate Outcome | New virions produced | Phage genome maintained |
Host Survival | Typically lyses at release | Host survives and reproduces |
Key Term | Virulent phage | Temperate phage |
Genome State | Active for virion production | Prophage, often integrated |
Transition | Ends with release | Induction can initiate lytic cycle |
Lytic Cycle Steps: Attachment → Penetration → Synthesis → Assembly → Release (cell lysis).
Lysogenic Cycle: Phage genome integrates as a prophage; host cell divides, passing on the prophage.
Induction: Stress (e.g., UV light) can trigger prophage to enter the lytic cycle.
Lysogenic Conversion: Prophage genes can alter bacterial traits (e.g., toxin production).
Terminology: Prophage (bacterial context); provirus (integrated animal-virus DNA).
Animal Virus Entry and Replication
The Animal Virus Replication Sequence
Animal viruses follow a general sequence for replication, with variations in entry and genome replication mechanisms.
Stages: Attachment → Entry → Uncoating → Biosynthesis → Assembly → Release
Entry Mechanisms:
Direct Penetration: Genome enters cell; capsid remains outside.
Membrane Fusion: Enveloped virus fuses with host membrane, delivering nucleocapsid.
Receptor-Mediated Endocytosis: Virion is taken into a vesicle, then escapes into cytoplasm.
Biosynthesis: Viral genome directs synthesis of proteins and genome copies using host (and sometimes viral) enzymes.
DNA Viruses: Usually replicate in the nucleus.
RNA Viruses: Usually replicate in the cytoplasm (exceptions: influenza, poxviruses).
Retroviral Replication
Retroviruses, such as HIV, use reverse transcription to integrate their genome into the host DNA.
Attachment and entry into the host cell.
Reverse transcriptase synthesizes DNA from the RNA genome.
Viral integrase inserts the DNA into the host chromosome (provirus).
Host transcription produces viral RNA and proteins.
Assembly, budding, and maturation yield new virions.
Reverse Transcriptase: RNA-dependent DNA polymerase packaged in the virion.
Note: Not all RNA viruses use reverse transcription (e.g., hepatitis B uses a related mechanism).
Virus Release and Infection Patterns
Release Mechanisms: Lysis (cell destruction), budding (enveloped viruses), exocytosis.
Latency: Genome persists with little or no infectious particle production between reactivations (e.g., herpesviruses).
Chronic Productive Infection: Continuous or fluctuating viral production over time.
Persistent Infection: Encompasses both latency and chronic productive infection.
Integration: Latency does not always require integration; herpesviruses often persist as episomes.
Viruses and Cancer
How Infection Can Promote Tumors
Some viruses can contribute to cancer development by altering host cell growth controls.
Proto-oncogenes: Normal genes regulating cell growth; can become oncogenes if mutated or overactive.
Tumor-Suppressor Genes: Inhibit cell division; loss or inactivation can promote cancer.
Viral Mechanisms:
Insertion near growth-control genes
Expression of proteins disrupting cell-cycle regulation
Chronic inflammation and immune suppression
Some retroviruses carry oncogenes
Examples:
High-risk HPV: Cervical and other cancers (interferes with tumor suppressors)
Hepatitis B/C: Liver cancer (chronic inflammation)
Epstein-Barr virus: Lymphomas, nasopharyngeal cancer
HTLV-1: Adult T-cell leukemia/lymphoma
HHV-8/KSHV: Kaposi sarcoma
HIV: Indirectly increases cancer risk via immune suppression
Prevention: Vaccines (HPV, hepatitis B), screening, and treatment of chronic infections.
Estimate: About 15% of human cancers are associated with viral infections (introductory estimate; check your course edition for specifics).
Cultivating and Counting Viruses
Why Living Cells Are Required
Viruses require living, susceptible, and permissive cells for replication; they cannot multiply on nutrient agar alone.
Method | Description | Strengths and Limitations |
|---|---|---|
Living Animals | Inoculate susceptible animals; observe infection/immune response | Whole-organism study; costly, ethical concerns, species differences |
Embryonated Eggs | Inoculate membranes/cavities in live eggs | Supports selected viruses, vaccine production; not universal |
Cell Culture | Grow susceptible cells in nutrient medium, then inoculate virus | Controlled, useful for isolation; host choice and contamination matter |
HeLa Cells: Continuous human cell line from Henrietta Lacks; divides indefinitely in culture.
Primary Culture: Freshly derived from tissue; limited lifespan.
Plaque Assay for Measuring Infectious Virus
Plaque assays estimate the number of infectious virus particles (plaque-forming units, PFU) in a sample.
Serially dilute virus, apply to susceptible cell monolayer or bacterial lawn under an overlay.
Each plaque represents local cell destruction from infection.
PFU/mL Calculation:
Example: 50 plaques from 0.1 mL of a 10-6 dilution: PFU/mL.
Note: PFU is an operational measure; not every virion forms a plaque.
Egg-Based Vaccines and Egg Allergies
Some vaccines (e.g., influenza) are produced in embryonated eggs; residual egg proteins may be present.
Current U.S. guidance: Egg allergy does not preclude receiving egg-based influenza vaccines; only severe reactions to previous vaccines require special consideration.
Other vaccines (e.g., yellow fever) may have different recommendations.
Viruses, Viroids, and Prions
Comparison of Acellular Infectious Agents
Feature | Virus | Viroid | Prion |
|---|---|---|---|
Structure | Genome inside capsid; some have envelope | Small, circular, single-stranded RNA; no capsid | Infectious misfolded protein |
Genetic Material | DNA or RNA | RNA | None |
Protein Coding | Encodes viral proteins | Does not encode proteins | No nucleic-acid genome |
Multiplication | Genome-directed synthesis and assembly in host cells | Host enzymes copy RNA (rolling-circle) | Abnormal protein templates misfolding of normal host protein |
Hosts | Bacteria, archaea, animals, plants | Mainly plants | Humans and other animals |
Examples | Influenza, HIV, bacteriophages | Potato spindle tuber viroid | BSE, vCJD, scrapie |
Viroids: Small, circular RNA molecules; infect plants; lack capsid and protein-coding genes.
Prions: Infectious proteins; no nucleic acid; cause transmissible spongiform encephalopathies (TSEs).
Prion Protein Misfolding
Prion diseases result from the accumulation of misfolded prion proteins, which induce further misfolding in normal host proteins.
Normal Prion Protein (PrPC): Can be converted to the disease-associated form (PrPSc).
Propagation: Misfolded PrPSc templates conversion of PrPC without genome replication.
Pathology: Accumulation causes neuronal loss, gliosis, and spongiform changes in the brain.
Diseases: BSE (mad cow disease) in cattle; vCJD in humans (linked to BSE exposure); classic CJD (sporadic, inherited, or acquired).
Transmission: Not all prion diseases are acquired; some arise sporadically or via inherited mutations.
Disinfection: Prions resist routine sterilization; require specialized protocols.
Practice Questions and Key Concepts
Viruses are acellular, lack independent metabolism, and require host cells for replication.
Virion = complete particle; capsid = protein coat; envelope = host-derived lipid membrane with viral proteins.
Attachment depends on specific host receptors; replication requires compatible internal factors.
Tobacco mosaic filtration showed a filterable agent, not direct proof of acellularity.
Enveloped viruses are more sensitive to detergents due to their lipid envelope.
Lytic cycle: attachment, penetration, biosynthesis, assembly, release.
Prophage: phage genome maintained in bacteria; induction triggers lytic cycle.
Animal virus entry: membrane fusion, endocytosis, or direct penetration.
Retroviral replication: attachment/entry → reverse transcription → integration → RNA/protein production → assembly/release.
Latent infection: little/no virus production between reactivations; chronic productive: continuous production.
Proto-oncogene: normal growth; oncogene: excessive growth. Viruses promote cancer by gene insertion, protein expression, inflammation, or immune suppression.
About 15% of human cancers are virus-associated (introductory estimate).
Virus cultivation: living animals, embryonated eggs, or cell cultures.
Plaque assay:
Egg allergy does not automatically preclude egg-based influenza vaccines under current U.S. guidance.
Viroid: circular RNA without capsid; prion: infectious protein, no nucleic acid.
Prions propagate by templating misfolding, not by genome replication.
BSE (cattle) and vCJD (humans) are linked prion diseases.
Summary Table: Key Differences Among Viruses, Viroids, and Prions
Agent | Genome | Capsid | Envelope | Replication | Hosts |
|---|---|---|---|---|---|
Virus | DNA or RNA | Yes | Sometimes | Genome-directed in host cell | Bacteria, plants, animals |
Viroid | RNA (circular, small) | No | No | Host enzymes copy RNA | Plants |
Prion | None | No | No | Protein misfolding templating | Animals, humans |
Additional info: These notes are aligned with Pearson Microbiology learning goals for Chapter 13 and include expanded academic context for clarity and exam preparation.